Author | Genovefa A. Papanicolaou, MD


Screening and Prevention of Hepatitis B Virus Reactivation During Chemotherapy

December 15, 2015

ByEmmy Ludwig, MD|Nina Cohen, PharmD|Genovefa A. Papanicolaou, MD|Susan K. Seo, MD

The incidence of both hepatitis B virus infection and cancer is common. The use of immunosuppressive therapy in patients with hepatitis B virus can result in reactivation of hepatitis B virus, which can, in turn, lead to significant morbidity and mortality.